These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33395234)

  • 1. Three ways COVID-19 makes the Oncology Care First Model more attractive.
    Macmillan K
    Am J Manag Care; 2020 Oct; 26(8 Spec No.):SP253-SP254. PubMed ID: 33395234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncertainty from COVID-19 delays progress on the road to value-based cancer care.
    Neubauer M; Jones B
    Am J Manag Care; 2020 Oct; 26(8 Spec No.):SP251-SP252. PubMed ID: 33395233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Timeline: Centers for Medicare and Medicaid Services (CMS) Changes and Primary Care Support Were Not Enough to Prevent Practice Losses.
    Gausvik C; Jabbarpour Y
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S7-S9. PubMed ID: 33622808
    [No Abstract]   [Full Text] [Related]  

  • 4. Delivering high-quality vascular care by telehealth during the COVID-19 pandemic.
    Fankhauser GT
    J Vasc Surg; 2020 Jul; 72(1):6-7. PubMed ID: 32289437
    [No Abstract]   [Full Text] [Related]  

  • 5. Telehealth Policies Impacting Federally Qualified Health Centers in Face of COVID-19.
    Sodhi M
    J Rural Health; 2021 Jan; 37(1):158-160. PubMed ID: 32277779
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and mental health in America: Crisis and opportunity?
    Nielsen M; Levkovich N
    Fam Syst Health; 2020 Dec; 38(4):482-485. PubMed ID: 33591784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telemedicine Services During COVID-19: Considerations for Medically Underserved Populations.
    Woodall T; Ramage M; LaBruyere JT; McLean W; Tak CR
    J Rural Health; 2021 Jan; 37(1):231-234. PubMed ID: 32613657
    [No Abstract]   [Full Text] [Related]  

  • 8. Telemedicine for Cancer Care in the Time of COVID-19.
    Royce TJ; Sanoff HK; Rewari A
    JAMA Oncol; 2020 Nov; 6(11):1698-1699. PubMed ID: 32672821
    [No Abstract]   [Full Text] [Related]  

  • 9. Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray.
    Gupta R; Ibraheim MK; Doan HQ
    J Am Acad Dermatol; 2020 Jul; 83(1):168-169. PubMed ID: 32334056
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
    Schmidt AL; Bakouny Z; Bhalla S; Steinharter JA; Tremblay DA; Awad MM; Kessler AJ; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang HH; Anderson-Keightly HM; Abou Alaiwi S; Rosenbloom TD; Stewart PS; Galsky MD; Choueiri TK; Doroshow DB
    Cancer Cell; 2020 Dec; 38(6):769-770. PubMed ID: 33176161
    [No Abstract]   [Full Text] [Related]  

  • 11. Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption.
    Lin LA; Fernandez AC; Bonar EE
    JAMA Psychiatry; 2020 Dec; 77(12):1209-1210. PubMed ID: 32609317
    [No Abstract]   [Full Text] [Related]  

  • 12. Achieving Equity in Telehealth: "Centering at the Margins" in Access, Provision, and Reimbursement.
    Westby A; Nissly T; Gieseker R; Timmins K; Justesen K
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S29-S32. PubMed ID: 33622814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ensuring access to health care by FQHCs as states reopen amid COVID-19.
    Sodhi M
    Am J Manag Care; 2020 Nov; 26(11):462-463. PubMed ID: 33196278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding Patient-Reported Outcomes to Medicare's Oncology Value-Based Payment Model.
    Basch E; Wilfong L; Schrag D
    JAMA; 2020 Jan; 323(3):213-214. PubMed ID: 31895416
    [No Abstract]   [Full Text] [Related]  

  • 15. Logistics of Rehabilitation Telehealth: Documentation, Reimbursement, and Health Insurance Portability and Accountability Act.
    Chan AH
    Phys Med Rehabil Clin N Am; 2021 May; 32(2):429-436. PubMed ID: 33814067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Emergency Medical Treatment and Active Labor Act: impact on telemedicine for neurotrauma.
    Shah S; Yang GL; Le DT; Gerges C; Wright JM; Parr AM; Cheng JS; Ngwenya LB
    Neurosurg Focus; 2020 Nov; 49(5):E8. PubMed ID: 33130613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    Lurie N; Experton B
    JAMA; 2021 Jan; 325(1):21-22. PubMed ID: 33211081
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and cancer care: What have we learned?: Despite the enormous challenges, researchers are sharing valuable lessons regarding evaluating risks, setting priorities, and communicating with patients during the pandemic.
    Nelson B; Kaminsky DB
    Cancer Cytopathol; 2020 Dec; 128(12):879-880. PubMed ID: 33264512
    [No Abstract]   [Full Text] [Related]  

  • 19. Telemedicine health disparities in oncology care.
    Wozniak AM; Rallis KS; Elkaddoum R
    Future Oncol; 2021 May; 17(14):1695-1698. PubMed ID: 33631991
    [No Abstract]   [Full Text] [Related]  

  • 20. The Tele-Future is Now: Will Telemedicine's Footprint Be Permanent Post-COVID-19?
    Berlin J
    Tex Med; 2020 Jul; 116(7):14-19. PubMed ID: 32872705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.